These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3244425)

  • 1. [Sensitivity and specificity of the dipyridamole test at rest in a group of patients with effort angina. Presentation of cases].
    Doria G; Lo Guidice P; Raciti S; Gulizia M; Circo A
    Minerva Cardioangiol; 1988 Nov; 36(11):569-73. PubMed ID: 3244425
    [No Abstract]   [Full Text] [Related]  

  • 2. [What coronary findings predispose to premature termination of a strong positive dipyridamole test?].
    Grosse-Heitmeyer W
    Wien Med Wochenschr; 1993; 143(11):301-5. PubMed ID: 8212717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dipyridamole test in the diagnosis of ischemic heart disease in women].
    Liakishev AA; Sidorenko BA; Akhmedzhanov NM; Matveeva LS; Krasnosel'skiĭ AM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):21-5. PubMed ID: 6508922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic documentation of myocardial ischemia in presence of angina pectoris without ST-T changes.
    Picano E; Distante A; Masini M; Moscarelli E; Lattanzi F; Lombardi M; Morales MA; L'Abbate A
    Can J Cardiol; 1986 Jul; Suppl A():67A-70A. PubMed ID: 3756601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of ergometer and dipyridamole echocardiography in patients with suspected coronary heart disease].
    Deutsch HJ; Schenkel C; Klaer R; Curtius JM
    Z Kardiol; 1994 Jun; 83(6):446-53. PubMed ID: 8067047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences between women and men in the dipyridamole test. Symptomatic and electrocardiography findings in patients with coronary heart disease].
    Grosse-Heitmeyer W; Huber T
    Med Klin (Munich); 1994 May; 89(5):233-9. PubMed ID: 8052176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of the dipyridamole test in diagnosing chronic ischemic heart disease].
    Simorot VN
    Vrach Delo; 1986 Feb; (2):49-53. PubMed ID: 3705568
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease.
    Bodi V; Sanchis J; Lopez-Lereu MP; Nunez J; Mainar L; Monmeneu JV; Husser O; Dominguez E; Chorro FJ; Llacer A
    J Am Coll Cardiol; 2007 Sep; 50(12):1174-9. PubMed ID: 17868810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The peroral dipyridamole test in the diagnosis of coronary insufficiency].
    Miklová E; Simícek J; Stverák P; Michalík D
    Vnitr Lek; 1989 Sep; 35(9):921-3. PubMed ID: 2815607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of an ischemia test in men and women with stable angina pectoris in clinical practice. Results of the heart catheter registry of the Working Society of Senior Hospital Cardiologists].
    Friedrich J; Tebbe U; Weber M; Gottwik M; Bonzel T; Hochadel M; Zahn R; Senges J; Zeymer U;
    Dtsch Med Wochenschr; 2006 May; 131(19):1078-84. PubMed ID: 16685628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the echo-dipyridamole test in the diagnosis of coronary disease in patients with associated aortic stenosis].
    Amadei G; Carioli E; Kubbajeh M; Baggioni GF
    Ital Heart J Suppl; 2000 Jan; 1(1):110-5. PubMed ID: 10832127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy.
    Casanova R; Varani E; Balducelli M; Patroncini A; Fabbri M; Maresta A
    J Invasive Cardiol; 1994; 6(1):1-6. PubMed ID: 10146699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of systolic time intervals in the dipyridamole test for the diagnosis of coronary disease].
    Gawor Z; Cholewa M; Markiewicz K
    Z Gesamte Inn Med; 1988 May; 43(9):234-8. PubMed ID: 3407237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole test in angina pectoris: diagnostic value and pathophysiological implications.
    Tavazzi L; Previtali M; Salerno JA; Chimienti M; Ray M; Medici A; Specchia G; Bobba P
    Cardiology; 1982; 69(1):34-41. PubMed ID: 7074663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dipyridamole test. Its place in the functional diagnosis of coronary insufficiency].
    Spacek R; Kozák P; Cervenka V; Hes I; Stárek A; Sklenár V
    Vnitr Lek; 1985 Jun; 31(6):542-8. PubMed ID: 4036021
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dipyridamole test as screening method in coronary disease].
    Tauchert M
    Internist (Berl); 1977 Nov; 18(11):588-93. PubMed ID: 340406
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of the echo-dipyridamole test in the differential diagnosis of chest pain].
    Piccone U; Potenza S; Pala M; Bongarzoni A; Regalia F
    Minerva Cardioangiol; 1993 Oct; 41(10):439-44. PubMed ID: 8302440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dipyridamole test in coronary disease diagnosis].
    Petelenz T; Kozakiewicz K; Nowak S; Flak Z; Czyz Z
    Pol Merkur Lekarski; 1998 Sep; 5(27):117-9. PubMed ID: 10101473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medicamentous induction of an angina pectoris as a new test in the preliminary diagnosis of coronary heart disease (CHD)].
    Tauchert M; Osterspey A; Hötzel J; Behrenbeck DW; Hilger HH
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1153-5. PubMed ID: 1029946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with nitro derivatives and the development of tolerance: a comparative study with stress ECG and dipyridamole ECG].
    Ferraro S; Ambrosio G; Bellarosa I; Codella C; Liguori L; Mininni N; Chiariello M
    G Ital Cardiol; 1999 May; 29(5):540-8. PubMed ID: 10367222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.